Literature DB >> 18825480

Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease.

Carlos A Camargo1, Adit A Ginde, Sunday Clark, Charles P Cartwright, Ann R Falsey, Dennis E Niewoehner.   

Abstract

The objective of this study is to determine the prevalence of respiratory syncytial virus (RSV) and other viral respiratory pathogens in emergency department (ED) patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). COPD patients presenting to the ED with <10 days of AECOPD symptoms were eligible. We used PCR to test nasal swabs for common viral respiratory pathogens. We completed viral studies on 76 patients from two EDs. Patients had a mean age of 72 years, and were 68% male, 99% white, and 29% current smokers. Influenza vaccination was reported by 87%. Viruses were detected in 19 of 76 patients (25%). These included RSV A (2) and B (4); parainfluenza 1 (1), 2 (0), and 3 (2); influenza A (3) and B (0); rhinovirus (4); and human metapneumovirus (3). A putative viral etiology was identified in 25% of AECOPD presenting for emergency care, of which approximately one-third were RSV-related.

Entities:  

Mesh:

Year:  2008        PMID: 18825480     DOI: 10.1007/s11739-008-0197-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  26 in total

1.  Improved detection of rhinoviruses in clinical samples by using a newly developed nested reverse transcription-PCR assay.

Authors:  A C Andeweg; T M Bestebroer; M Huybreghs; T G Kimman; J C de Jong
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

2.  Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness.

Authors:  Ann R Falsey; Maria A Formica; Edward E Walsh
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Respiratory viral infections in adults with and without chronic obstructive pulmonary disease.

Authors:  S B Greenberg; M Allen; J Wilson; R L Atmar
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

4.  Human metapneumovirus infection in adults with community-acquired pneumonia and exacerbation of chronic obstructive pulmonary disease.

Authors:  M E Hamelin; S Côté; J Laforge; N Lampron; J Bourbeau; K Weiss; R Gilca; G DeSerres; G Boivin
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079

5.  Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness.

Authors:  Ann R Falsey; Mary C Criddle; Edward E Walsh
Journal:  J Clin Virol       Date:  2006-01       Impact factor: 3.168

6.  A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD.

Authors:  Anastasia F Hutchinson; Anil K Ghimire; Michelle A Thompson; Jim F Black; Caroline A Brand; Adrian J Lowe; David M Smallwood; Ross Vlahos; Steven Bozinovski; Graham V Brown; Gary P Anderson; Louis B Irving
Journal:  Respir Med       Date:  2007-09-05       Impact factor: 3.415

Review 7.  Viral infections in patients with chronic obstructive pulmonary disease.

Authors:  Jay B Varkey; Basil Varkey
Journal:  Curr Opin Pulm Med       Date:  2008-03       Impact factor: 3.155

8.  Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization assay (Hexaplex).

Authors:  J Fan; K J Henrickson; L L Savatski
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

9.  Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.

Authors:  Ann R Falsey; Maria A Formica; John J Treanor; Edward E Walsh
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Human metapneumovirus and chronic obstructive pulmonary disease.

Authors:  Diego Vicente; Milagrosa Montes; Gustavo Cilla; Emilio Pérez-Trallero
Journal:  Emerg Infect Dis       Date:  2004-07       Impact factor: 6.883

View more
  30 in total

1.  Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments.

Authors:  Bernardino Roca; Pedro Almagro; Francisco López; Francisco J Cabrera; Lorena Montero; David Morchón; Jesús Díez; Fernando de la Iglesia; Mario Fernández; Jesús Castiella; Elena Zubillaga; Jesús Recio; Joan B Soriano
Journal:  Intern Emerg Med       Date:  2010-10-01       Impact factor: 3.397

Review 2.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

3.  Respiratory syncytial virus infection in older adults: an under-recognized problem.

Authors:  Angela R Branche; Ann R Falsey
Journal:  Drugs Aging       Date:  2015-04       Impact factor: 3.923

Review 4.  Bringing Stability to the Chronic Obstructive Pulmonary Disease Patient: Clinical and Pharmacological Considerations for Frequent Exacerbators.

Authors:  Swati Gulati; J Michael Wells
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

Review 5.  The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma.

Authors:  Richard Hewitt; Hugo Farne; Andrew Ritchie; Emma Luke; Sebastian L Johnston; Patrick Mallia
Journal:  Ther Adv Respir Dis       Date:  2015-11-26       Impact factor: 4.031

6.  Full-genome sequence and analysis of a novel human rhinovirus strain within a divergent HRV-A clade.

Authors:  Jennifer A Rathe; Xinyue Liu; Luke J Tallon; James E Gern; Stephen B Liggett
Journal:  Arch Virol       Date:  2009-11-20       Impact factor: 2.574

7.  Human metapneumovirus establishes persistent infection in the lungs of mice and is reactivated by glucocorticoid treatment.

Authors:  Yuru Liu; Debra L Haas; Spencer Poore; Sanjin Isakovic; Michelle Gahan; Suresh Mahalingam; Zhen F Fu; Ralph A Tripp
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

8.  Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Xiaodong Wu; Du Chen; Xiaoling Gu; Xin Su; Yong Song; Yi Shi
Journal:  Mol Biol Rep       Date:  2014-04-02       Impact factor: 2.316

9.  Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.

Authors:  Allison L Miller; Gary P Sims; Yambasu A Brewah; Marlon C Rebelatto; Jennifer Kearley; Ebony Benjamin; Ashley E Keller; Philip Brohawn; Ronald Herbst; Anthony J Coyle; Alison A Humbles; Roland Kolbeck
Journal:  J Infect Dis       Date:  2012-01-18       Impact factor: 5.226

Review 10.  Challenge models to assess new therapies in chronic obstructive pulmonary disease.

Authors:  René van der Merwe; Nestor A Molfino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.